Jane Street’s Aptose Biosciences, Inc. APTO Stock Holding History

Jane Street’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22	Closed	-$61K	–	8319
2020 Q3	$61K	Buy	+22	New	+$54.9K	﹤0.01%	6883

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street's APTO Position: Q2 2023 in Review

Jane Street sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 27 shares — an estimated $7.63K sold.

Jane Street first reported a position in APTO in Q4 2016 and held it in 9 quarters. The position peaked at $69K in Q3 2020. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

Jane Street reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
Jane Street sold 27 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $7.63K.
Jane Street first reported a position in Aptose Biosciences, Inc. in Q4 2016 and held it in 9 quarters.
Jane Street's Aptose Biosciences, Inc. position peaked at $69K in Q3 2020.
24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.